Observational study through a survey of dermatologists in Colombia: diagnosis and preferred treatments in patients with atopic dermatitis
DOI:
https://doi.org/10.29176/2590843X.1828Keywords:
Adult, Atopic dermatitis, Biological therapy, Immunosuppressants, Phototherapy, TreatmentAbstract
Background: Atopic dermatitis (AD) is an increasingly studied immune-mediated disease. The aim of this study is to identify the diagnostic criteria, clinical assessment scales, and preferred treatments. In addition, the selection and changes of therapy strategies, and the waiting time to see the therapeutic response.
Methods: It is an observational, descriptive cross-sectional study. It was done through a virtual survey distributed during academic activities, after carrying out a pilot test.
Results: 68 dermatologists were surveyed, 29.3% based the diagnosis according to the clinic, followed by the Hanifin-Rajka criteria (23.08%). The most used rating scales were DLQI, EASI, and clinical assessment (29.85%). The first therapeutic line for mild disease was corticosteroids of medium potency (52.31%). In the second line, they preferred a change in corticosteroid potency (38.46%). The main causes of starting systemic therapy were: 1. severe symptoms and 2. severe alteration of quality of life. To choose systemic therapy, the clinical severity and the efficacy of the drug according to the literature were taken into account. In moderate-severe AD, the first option was phototherapy (59.38%) and systemic corticosteroids (25%). As a second option, cyclosporine (25%), phototherapy (18.75%), azathioprine (18.75%).
Conclusions: It is the first study in Latin America in this regard. It was found that there is no consensus on the diagnosis and management of the disease. In some cases, the necessary time to see a clinical response is not being reached. It provides unique information on the treatment of atopic dermatitis and suggests carrying out academic activities to unify concepts among specialists.
Author Biographies
Marcela Cardona Salazar, Consultorio privado
Dermatóloga
Carolina Ivette Cortés-Correa, Consultorio privado
Dermatóloga
Elkin Peñaranda, Consultorio privado
Dermatólogo oncólogo
Héctor José Castellanos-Lorduy, Consultorio privado
Dermatólogo
References
Claudia Patricia Ordoñez, Tamayo LM, Gamboa LA, et al. Guía de práctica clínica (GPC) para el diagnóstico y tratamiento de la dermatitis atópica en Colombia. Rev la Asoc Colomb Dermatología y Cirugía Dermatológica. Published online 2018:1-250.
Wollenberg A, Christen-Zach S, Taieb A, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatology Venereol. 2020;34(12):2717-2744. https://doi.org/10.1111/jdv.16892
Andersen RM, Thyssen JP, Maibach HI. Qualitative vs. quantitative atopic dermatitis criteria - In historical and present perspectives. J Eur Acad Dermatology Venereol. 2016;30(4):604-618. https://doi.org/10.1111/jdv.13442
Vakharia PP, Chopra R, Silverberg JI. Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials. Am J Clin Dermatol. 2018;19:15-22. https://doi.org/10.1007/s40257-017-0299-4
Simpson EL, Keck LE, Chalmers JR, Williams HC. How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies. J Allergy Clin Immunol. 2012;130(1):137-144. https://doi.org/10.1016/j.jaci.2012.01.075
Taylor K, Swan DJ, Affleck A, Flohr C, Reynolds NJ. Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists. Br J Dermatol. 2017;176(6):1617-1623. https://doi.org/10.1111/bjd.15235
Vermeulen FM, Gerbens LAA, Schmitt J, et al. The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczema. Br J Dermatol. 2020;183(6):1073-1082. https://doi.org/10.1111/bjd.18959
(Invima) IN de V de N y A. CONSULTA DATOS DE PRODUCTOS. Published online 2007. http://consultaregistro.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jsp
Majoie IML, Oldhoff JM, van Weelden H, et al. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol. 2009;60(1):77-84. https://doi.org/10.1016/j.jaad.2008.08.048
Rodenbeck DL, Silverberg JI, Silverberg NB. Phototherapy for atopic dermatitis. Clin Dermatol. 2016;34(5):607-613. https://doi.org/10.1016/j.clindermatol.2016.05.011
Ordóñez Rubiano MF, Arenas CM, Chalela JG. UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country. Int J Dermatol. 2018;57(7):799-803. https://doi.org/10.1111/ijd.14011
Davari DR, Nieman EL, McShane DB, Morrell DS. Current perspectives on the systemic management of atopic dermatitis. J Asthma Allergy. 2021;14:595-607. https://doi.org/10.2147/JAA.S287638
Prezzano JC, Beck LA. Long-Term Treatment of Atopic Dermatitis. Dermatol Clin. 2017;35(3):335-349. https://doi.org/10.1016/j.det.2017.02.007
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Marcela Cardona Salazar, Carolina Ivette Cortés-Correa, Elkin Peñaranda, Héctor José Castellanos-Lorduy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
